Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?

Gut Liver. 2023 Sep 15;17(5):668-669. doi: 10.5009/gnl230338.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Clarithromycin* / therapeutic use
  • Drug Resistance
  • Humans

Substances

  • Clarithromycin
  • tegoprazan